Figure 1From: Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria – experiences from the Danish Cystic Fibrosis cohort study Flow chart of cystic fibrosis patients included in the LAM study. LAM = Lipoarabinomannan, NTM = nontuberculous mycobacteria, MABSC = Mycobacterium abscessus complex, MAC = Mycobacterium avium complex. (n) *Number of LAM positive patients if the grade 1 cut-point was used.Back to article page